Difference between revisions of "ECG-SINUS ARRHYTHMIA (BRADYCARDIA)"
From NeuroRehab.wiki
(Imported from text file) |
(Imported from text file) |
||
Line 1: | Line 1: | ||
[[Summary Article|<h5>'''SUMMARY ARTICLE'''</h5>]] | [[Summary Article|<h5>'''SUMMARY ARTICLE'''</h5>]] | ||
<br/> | <br/> | ||
<div>1. Sinus bradycardia originates in the SA node. <br>2. Due to reduced sympathetic input or excessive vagal tone. <br><i>3. Causes: inferior AMI, hypoxia, hypothermia, drugs (beta-blockers, verapamil, flecanide).</i><br>4. At moderately slow rates patient may be asymptomatic. <br>5. At slower rates, patient may become hypotensive & symptomatic. <br>6. Management: aimed at increasing HR (Atropine). <br><br><div>[[Image:paste-0b2c87f93e74dd5f195a0f9c49a8fdb161104467.jpg]]<br></div> | <div>1. Sinus bradycardia originates in the SA node. <br/>2. Due to reduced sympathetic input or excessive vagal tone. <br/><i>3. Causes: inferior AMI, hypoxia, hypothermia, drugs (beta-blockers, verapamil, flecanide).</i><br/>4. At moderately slow rates patient may be asymptomatic. <br/>5. At slower rates, patient may become hypotensive & symptomatic. <br/>6. Management: aimed at increasing HR (Atropine). <br/><br/><div>[[Image:paste-0b2c87f93e74dd5f195a0f9c49a8fdb161104467.jpg]]<br/></div> | ||
[[Category:Electrocardiogram]] | [[Category:Electrocardiogram]] | ||
[[Category:Advanced Life Support]] | [[Category:Advanced Life Support]] |
Revision as of 12:30, 21 December 2022
SUMMARY ARTICLE
1. Sinus bradycardia originates in the SA node.
2. Due to reduced sympathetic input or excessive vagal tone.
3. Causes: inferior AMI, hypoxia, hypothermia, drugs (beta-blockers, verapamil, flecanide).
4. At moderately slow rates patient may be asymptomatic.
5. At slower rates, patient may become hypotensive & symptomatic.
6. Management: aimed at increasing HR (Atropine).
2. Due to reduced sympathetic input or excessive vagal tone.
3. Causes: inferior AMI, hypoxia, hypothermia, drugs (beta-blockers, verapamil, flecanide).
4. At moderately slow rates patient may be asymptomatic.
5. At slower rates, patient may become hypotensive & symptomatic.
6. Management: aimed at increasing HR (Atropine).